CNE100003449
CNE100003449
BGI GENOMICS
Loading chart...
Pure Price Volatility Risk (Market Swings)
The business itself is financially solid (Financial Health 60/100, minimal insolvency risk). The high overall score (7/7) is driven primarily by extreme stock price swings (±41.6% p.a.) and steep historical drawdowns.
Volatility Risk
Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.
Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta
Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.7x).
Beta (Market Relation)
0.66x
DefensiveVolatility (5Y p.a.)
41.6% p.a.
5-Year HorizonMax Drawdown (5Y)
-67.5%
5-Year HorizonSharpe Ratio
-0.36
Return / RiskSpeculative / High Risk: Score Basis:
Multi-Horizon Risk & Performance Matrix
Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.
Volatility Expansion (3Y > 5Y) High Volatility
Timeframe | Volatility (p.a.) | Max Drawdown | Sharpe Ratio | Return (p.a.) |
|---|---|---|---|---|
| 1 Year | — | — | — | -9.3% |
| 3 Years | 44.8% | -50.4% | -0.15 | -4% |
| 5 Years | 41.6% | -67.5% | -0.36 | -12.2% |
| 10 Years | 48.8% | -87.2% | 0.14 | — |
Automated Risk & Health Notes (Red Flags)
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Unprofitable business model: The company is currently generating net losses.
🔴 High valuation risk: Avg P/E of 284.2 (Elevated multiple compression risk)
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (41.6% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -87.2% in the extended horizon.